All 307 REVS (COLUMBIA RESEARCH ENHANCED VALUE ETF) Holdings
There are 307 REVS holdings. Top 10 companies weight: 32.64%.
Total Market Cap: $20T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (307 stocks) | +15.58% | 23.68 | 18.92 | 0.51 | +15.27% | +12.81% | 0.93 | ||||||||||
301 | ASND | Ascendis Pharma As | 0.00% | $251.76 | $17B | Biotechnology | Healthcare | N/A | 30.09 | 16.39 | N/A | N/A | N/A | 80 | +19.78% | $302 | +15.59% | 0.44 |
302 | IONS | Ionis Pharmaceuticals Inc | 0.00% | $52.95 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +75.54% | $93 | +7.60% | 0.65 |
303 | n/a | Contra Mirati Therapeu Common Stock | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
304 | n/a | Contra Hologic Incorpo Common Stock | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
305 | n/a | Contra Walgreens Boots Common Stock | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
306 | BBIO | Bridgebio Pharma Inc | 0.00% | $80.76 | $16B | Biotechnology | Healthcare | -3.14% | N/A | N/A | N/A | N/A | N/A | 79 | +29.74% | $105 | +5.57% | 1.02 |
307 | CAI | Caris Life Sciences Inc | 0.00% | $15.56 | $4.94B | Biotechnology | Healthcare | N/A | N/A | 43.29 | N/A | N/A | N/A | 71 | +73.52% | $27 | 0.00% | 1.42 |
REVS (COLUMBIA RESEARCH ENHANCED VALUE ETF) Sector Allocation
INFORMATION TECHNOLOGY
19.70%FINANCIALS
19.20%HEALTHCARE
12.20%INDUSTRIALS
10.80%CONSUMER DISCRETIONARY
10.10%CONSUMER STAPLES
7.20%ENERGY
5.70%UTILITIES
3.90%COMMUNICATION SERVICES
3.70%MATERIALS
3.60%REAL ESTATE
0.00%